China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2012-07-31 01:30 Roche to Hire 1,000 New Employees in China 2012-07-29 01:30 Week in Review: Suzhou Connect Biopharma In-Licenses Anti-Inflammatories from Arena 2012-07-28 01:30 Transgene and Tasly JV Starts Operations with Four Transgene Molecules 2012-07-27 01:30 Officials: Chronic Disease Threatens China's Healthcare System 2012-07-26 01:30 Suzhou Connect Biopharma Gains Rights to Arena's Anti-Inflammatory Drugs 2012-07-25 01:30 SUMEC to Distribute Breast MRI Machines in China for Aurora 2012-07-24 01:30 Fenwal Holdings and Its China JV Bought by Fresenius of Germany 2012-07-22 01:30 The Week in Review: Jinhe Biotech Stages $79 Million IPO in Shenzhen 2012-07-21 01:30 WIBF and Refine Technology Collaborate on Vaccines 2012-07-20 01:30 TJAB Forms Drug Development JV with Antisense of Australia 2012-07-19 01:30 Chengdu Hoist Selling Animal Health Business and more... 2012-07-18 01:30 Shanghai Jia Fu Medical Apparatus Starts Stem Cell Clinical Trial and more... 2012-07-17 01:30 Jinhe Biotech Stages a $78.6 Million Shenzhen IPO and more... 2012-07-15 01:30 Week in Review: Ascletis In-Licenses China Rights to RNAi Cancer Drug 2012-07-14 01:30 Siegfried to Build API and Intermediates Plant in Nantong 2012-07-13 01:30 Ascletis In-Licenses Alynlam's RNAi Drug for Liver Cancer and more... 2012-07-12 01:30 HAO Capital and TCL Group to Set Up Medical Imaging JV 2012-07-11 01:30 Walvax Biotech Gains Majority Control of Fengmao Biotech 2012-07-10 01:30 SFDA Issues New Rules for Drug Excipients 2012-07-08 01:30 The Week in Review: ShangPharma Receives Go-Private Offer from Chairman 2012-07-07 01:30 ShangPharma's Chairman Offers to Take the Company Private and more... 2012-07-06 01:30 Beijing Starts Zero-Markup Policy on Drugs from Local Hospital 2012-07-04 01:30 SEC Halts Trading in China Medical's Stock for Two Weeks 2012-07-03 01:30 ScinoPharm Building $37.6 Million Cancer Drug CMO in Tainan 2012-07-01 01:30 The Week in Review: China Pledges $18 Billion for Biopharma 2011-2020   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC